TickerFactsScreenerDevelopers

Travere Therapeutics, Inc. (TVTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$536.3K2012: -$3.41M2013: -$19.67M2014: -$37.25M2015: $299.97M2016: $307.77M2017: $293.13M2018: $318.25M2019: $221.20M2020: $211.21M2021: $302.11M2022: $42.85M2023: $200.81M2024: $59.08M2025: $114.83M$114.83M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$114.83M+94.4%
2024$59.08M-70.6%
2023$200.81M+368.6%
2022$42.85M-85.8%
2021$302.11M+43.0%
2020$211.21M-4.5%
2019$221.20M-30.5%
2018$318.25M+8.6%
2017$293.13M-4.8%
2016$307.77M+2.6%
2015$299.97M+905.3%
2014-$37.25M-89.4%
2013-$19.67M-477.1%
2012-$3.41M-535.5%
2011-$536.3K—